PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
26386269-2	2016	In this study, we evaluated the release kinetics and delivery efficacies of vascular endothelial growth factor (VEGF), a potent angiogenic growth factor, incorporated into calcium phosphate bone grafts (BGs).	calcium phosphate	172-189	vascular endothelial growth factor A	Rattus norvegicus	76-110	
26386269-2	2016	In this study, we evaluated the release kinetics and delivery efficacies of vascular endothelial growth factor (VEGF), a potent angiogenic growth factor, incorporated into calcium phosphate bone grafts (BGs).	calcium phosphate	172-189	vascular endothelial growth factor A	Rattus norvegicus	112-116	
25808925-0	2015	Effect of Local Sustainable Release of BMP2-VEGF from Nano-Cellulose Loaded in Sponge Biphasic Calcium Phosphate on Bone Regeneration.	calcium phosphate	95-112	vascular endothelial growth factor A	Rattus norvegicus	44-48	
25808925-4	2015	A biphasic calcium phosphate (BCP)-NC-BMP2-VEGF (BNBV) scaffold was fabricated for this purpose.	calcium phosphate	11-28	vascular endothelial growth factor A	Rattus norvegicus	43-47	
25709009-0	2015	Bone formation of a porous Gelatin-Pectin-biphasic calcium phosphate composite in presence of BMP-2 and VEGF.	calcium phosphate	51-68	vascular endothelial growth factor A	Rattus norvegicus	104-108	
28361415-1	2017	The study established enhanced expression of vascular endothelial growth factor (VEGF) in the subpopulation of osteoblasts located in the regeneration region of femoral bone fracture near the titanium implants with bioactive calcium phosphate and hydroxyapatite coatings and suppressed activity of transforming growth factor-beta2 (TGF-beta2) in chondroblasts during the two weeks after surgery.	calcium phosphate	225-242	vascular endothelial growth factor A	Rattus norvegicus	45-79	
28361415-1	2017	The study established enhanced expression of vascular endothelial growth factor (VEGF) in the subpopulation of osteoblasts located in the regeneration region of femoral bone fracture near the titanium implants with bioactive calcium phosphate and hydroxyapatite coatings and suppressed activity of transforming growth factor-beta2 (TGF-beta2) in chondroblasts during the two weeks after surgery.	calcium phosphate	225-242	vascular endothelial growth factor A	Rattus norvegicus	81-85